CTSOVSHALO• 3 Months (Normalized)
CTSO vs HALO (Cytosorbents Corporation vs Halozyme Therapeutics Inc.)
Showing Closing Date Range from Jul 8 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $3.96
+915.38%
Cytosorbents Corporation
Normalized Baseline0.00%
HALO Performance $109.72
+36.52%
Halozyme Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+878.86 pts
CTSO outperforming by 878.86 percentage points
CTSOHALO
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO HALO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | CTSO Price | CTSO Gain (%) | HALO Price | HALO Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $3.96 | +915.38% | $109.72 | +36.52% | +878.86% |
| Oct 05, 2026 | $3.97 | +916.67% | $108.31 | +34.76% | +881.91% |
| Oct 02, 2026 | $4.05 | +938.46% | $109.86 | +36.69% | +901.77% |
| Oct 01, 2026 | $- | $106.94 | +33.06% | - | |
| Sep 30, 2026 | $3.90 | +900.00% | $110.40 | +37.36% | +862.64% |
| Sep 29, 2026 | $4.00 | +925.64% | $111.56 | +38.81% | +886.83% |
| Sep 28, 2026 | $4.02 | +930.77% | $112.89 | +40.46% | +890.31% |
| Sep 25, 2026 | $4.38 | +1023.08% | $113.90 | +41.72% | +981.36% |
| Sep 24, 2026 | $4.30 | +1002.56% | $- | - | |
| Sep 23, 2026 | $4.91 | +1158.97% | $112.44 | +39.90% | +1119.07% |
| Sep 22, 2026 | $- | $115.13 | +43.25% | - | |
| Sep 21, 2026 | $5.51 | +1312.82% | $111.45 | +38.67% | +1274.15% |
| Sep 18, 2026 | $5.75 | +1374.36% | $112.45 | +39.92% | +1334.44% |
| Sep 17, 2026 | $5.76 | +1376.92% | $109.68 | +36.47% | +1340.45% |
| Sep 16, 2026 | $5.73 | +1369.23% | $108.44 | +34.93% | +1334.30% |
Page 1 of 5